HLC Immunity + Pro Natural Orange Flavor

product on market Powder Pharmax 🟢 Safety: 100/100
Brand: Pharmax
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 53% of ingredients have research evidence
A Label Compliance Grade

Product Label

Label for HLC Immunity + Pro Natural Orange Flavor
📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

8.42 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
53% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 {Calories}
Sodium
55 mg (2% DV)
Total Carbohydrates
6 Gram(s) (2% DV)
Vitamin C
1000 mg (1667% DV)
0.38 mg (25% DV)
✅ Within RDA (0.3× RDA of 1.2 mg) 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 0.38mg
0.43 mg (25% DV)
✅ Within RDA (0.3× RDA of 1.3 mg) 📚 12 studies (Tier A: 0, B: 1)
RDA 1.3mg This product: 0.43mg
5 mg (25% DV)
✅ Within RDA (0.4× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 5mg UL 35mg
10 mg (500% DV)
📊 7.7× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 10mg UL 100mg
12.5 mcg (3% DV)
📊 Market median: 667.0mg (446 products) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.0125mg UL 1.0mg
25 mcg (417% DV)
📊 10.4× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.025mg
2.5 mg (25% DV)
✅ Within RDA (0.5× RDA of 5 mg) 📚 1 studies — no high-quality reviews
RDA 5mg This product: 2.5mg
Calcium
50 mg (5% DV)
13 mg (1% DV)
📊 Market median: 99.0mg (503 products) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 13mg UL 4000mg
60 mg (15% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 60mg
2 mg (13% DV)
✅ Within RDA (0.2× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 2mg UL 40mg
0.5 mg (25% DV)
✅ Within RDA (0.2× RDA of 2.3 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 0.5mg UL 11mg
10 mcg (8% DV)
✅ Within RDA (0.3× RDA of 0.035 mg) 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.01mg
Potassium
100 mg (3% DV)
HLC Consortium

Other Ingredients

Crystalline Fructose Citric Acid DL-Malic Acid natural Orange flavor Sodium Bicarbonate Orange juice powder Maltodextrin Silica L-Tartaric Acid Glycine Annatto extract Beta-Carotene

Label Claims — Verification

❓ All Other
All Other (99% of products) Structure/Function (83% of products) Nutrient (54% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Recommended adult intake: In a glass, add water to one sachet of powder and mix. One sachet taken daily with a meal, a few hours before or after taking other medications, or as professionally directed.

⚠️ Warnings & Precautions

Risk information: If you have an immune-compromised condition, do not use. If symptoms of digestive upset occur, worsen or persist beyond three days, discontinue use and consult your healthcare practitioner.

Safety-sealed for your protection and for product freshness. Do not use if sachet has been tampered with.

Keep out of reach of children.

🧪 Formulation Notes

Pack size: 30-0.3 oz (8.42 g) sachets of powder

Gluten free, Dairy free and FOS free

Additional Information

Store in a cool, dry place.

V1.1 Code VM54-30

Contains Clinically Proven Probiotic Strains

Human Lactic Commensals (HLC) probiotic strains are research-driven and clinically proven in randomized, double-blind, placebo-controlled human trials at 10 billion CFU per day. Proprietary non-pathogenic human-sourced microflora bacterial strains are utilized as they have strong epithelial adherence and a naturally high tolerance to stomach acid.

Product Details

UPC / SKU 883196 21540
DSLD Entry Date 2016-01-25
Product Type Other Combinations
Form Powder
Brand Pharmax
DSLD ID 55759
Data Updated 2026-04-11

Research Evidence

371 Research Sources
54 Avg Quality Score
148 Meta Analysis
82 Systematic Review
71 Rct
62 Clinical Trial
2 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Other
1 Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI Cochrane
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI Cochrane
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI Cochrane
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI Cochrane
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021
PubMed DOI Cochrane
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024
PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024
PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021
PubMed DOI
View all evidence for Vitamin C →

Compare Similar Products

Mega-Dose Vitamin C DR.F 100
Ascorbic Acid (Vitamin C) Powder
Ascorbic Acid (Vitamin C) Powder TerraVita Premium Collection 100
Ascorbic Acid (Vitamin C) Powder TerraVita Premium Collection 100
Ascorbic Acid (Vitamin C) Hard Rhino 100
Ascorbic Acid (Vitamin C) Powder TerraVita Premium Collection 100
View all Vitamin C products →
Vitamin C research & evidence Best Vitamin C rankings All Vitamin C products More from Pharmax View on NIH DSLD →